THERESE BERTRAND: Open Payments
NPI 1942303508 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$520 in 18 payments from 8 companies in 2025. Trend: 2023 $1,346 · 2024 $976 · 2025 $520
Food & beverage: $520
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 7 | $168 |
| Novo Nordisk Inc | 1 | $124 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| Dexcom, Inc. | 2 | $50 |
| Abbott Laboratories | 2 | $43 |
| PFIZER INC. | 1 | $30 |
| Boston Scientific Corporation | 1 | $26 |
| Exact Sciences Corporation | 1 | $22 |
Products named: Ozempic, MOUNJARO, Dexcom G6 Transmitter, FREESTYLE LIBRE 3, NURTEC ODT, WATCHMAN FLX, JARDIANCE, ZEPBOUND.
Industry payments across TX — which companies pay providers there.
